Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma

Clinical trial NCT01100242 · TERMINATED

Trial details

NCT number: NCT01100242
Sponsor: New Mexico Cancer Research Alliance
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2010-04-01
Primary completion: 2014-01-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.